Hideki Ukawa

749 total citations
18 papers, 631 citations indexed

About

Hideki Ukawa is a scholar working on Surgery, Pharmacology and Physiology. According to data from OpenAlex, Hideki Ukawa has authored 18 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Pharmacology and 6 papers in Physiology. Recurrent topics in Hideki Ukawa's work include Inflammatory mediators and NSAID effects (11 papers), Helicobacter pylori-related gastroenterology studies (11 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Hideki Ukawa is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Helicobacter pylori-related gastroenterology studies (11 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Hideki Ukawa collaborates with scholars based in Japan and Switzerland. Hideki Ukawa's co-authors include Koji Takeuchi, Shinichi Kato, Hideo Araki, Akira Konaka, Osamu Furukawa, Shuh Narumiya, Fumitaka Ushikubi, Katsunori Suzuki, Yoshihiro Ogawa and Yusaku Komoike and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Hideki Ukawa

17 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Ukawa Japan 12 345 254 169 149 132 18 631
Yusaku Komoike Japan 15 301 0.9× 225 0.9× 70 0.4× 74 0.5× 93 0.7× 21 579
Tohru Miyazawa Japan 8 240 0.7× 191 0.8× 76 0.4× 56 0.4× 96 0.7× 13 533
Adrian Bak Canada 4 296 0.9× 101 0.4× 70 0.4× 127 0.9× 75 0.6× 10 468
Koji Takeuchi Japan 11 96 0.3× 212 0.8× 89 0.5× 33 0.2× 94 0.7× 18 448
Octávio Menezes de Lima Canada 5 252 0.7× 110 0.4× 31 0.2× 88 0.6× 91 0.7× 6 364
Hiromi Sugimoto Japan 12 130 0.4× 54 0.2× 186 1.1× 39 0.3× 185 1.4× 23 525
B. D. Soper Canada 12 62 0.2× 133 0.5× 110 0.7× 35 0.2× 127 1.0× 27 384
Hiroyasu Hirose Japan 10 53 0.2× 106 0.4× 136 0.8× 26 0.2× 132 1.0× 16 505
Inmaculada Ruz‐Maldonado United Kingdom 15 168 0.5× 278 1.1× 213 1.3× 12 0.1× 355 2.7× 21 740
Hiromi Iizuka Japan 7 253 0.7× 47 0.2× 45 0.3× 83 0.6× 72 0.5× 18 439

Countries citing papers authored by Hideki Ukawa

Since Specialization
Citations

This map shows the geographic impact of Hideki Ukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Ukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Ukawa more than expected).

Fields of papers citing papers by Hideki Ukawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Ukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Ukawa. The network helps show where Hideki Ukawa may publish in the future.

Co-authorship network of co-authors of Hideki Ukawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Ukawa. A scholar is included among the top collaborators of Hideki Ukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Ukawa. Hideki Ukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Takeuchi, Koji, et al.. (2002). Gastric ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors. Alimentary Pharmacology & Therapeutics. 16(s2). 74–82. 25 indexed citations
2.
Kato, Shinichi, Keizô Suzuki, Hideki Ukawa, Yusaku Komoike, & Koji Takeuchi. (2001). Low Gastric Toxicity of Nitric Oxide-Releasing Aspirin, NCX-4016, in Rats with Cirrhosis and Arthritis. Digestive Diseases and Sciences. 46(8). 1690–1699. 24 indexed citations
3.
Morita, Hitoshi, Yuko Hori, Hideki Ukawa, et al.. (2001). Effects of Z-360, a novel CCKB/gastrin (CCK2) receptor antagonist, on meal-induced acid secretion and experimental ulcer models in dogs and rats. Gastroenterology. 120(5). A311–A311. 5 indexed citations
4.
Yoneta, Tomoyuki, et al.. (2001). Pharmacological profiles of Z-360, a novel CCKB/gastrin (CCK2) receptor antagonist with excellent oral potency. Gastroenterology. 120(5). A311–A311. 9 indexed citations
5.
Araki, Hideo, et al.. (2000). The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach. Alimentary Pharmacology & Therapeutics. 14(s1). 116–124. 64 indexed citations
6.
Ukawa, Hideki, Shinichi Kato, Osamu Furukawa, et al.. (1999). Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E–receptor subtype EP3. Gastroenterology. 117(5). 1128–1135. 96 indexed citations
7.
Takeuchi, Koji, Hideki Ukawa, Osamu Furukawa, et al.. (1999). Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.. PubMed. 50(2). 155–67. 35 indexed citations
8.
Takeuchi, Koji, Hideki Ukawa, Osamu Furukawa, & Seiji Kato. (1998). Gastroduodenal bicarbonate secretion in mice with prostaglandin e receptor gene disruption. Gastroenterology. 114. A304–A304.
9.
Takeuchi, Koji, et al.. (1998). Prostaglandin E receptor subtypes involved in gastric cytoprotection against ethanol in rats. Gastroenterology. 114. A305–A305. 1 indexed citations
10.
Takeuchi, Koji, et al.. (1998). Effect of Nitric Oxide-Releasing Aspirin Derivative On Gastric Functional and Ulcerogenic Responses in Rats: Comparison With Plain Aspirin. Journal of Pharmacology and Experimental Therapeutics. 286(1). 115–121. 64 indexed citations
11.
Ukawa, Hideki, et al.. (1998). Effects of no-releasing aspirin on functional and mucosal ulcerogenic responses in the rat stomach: Comparison with aspirin. Gastroenterology. 114. A314–A315. 3 indexed citations
12.
Ukawa, Hideki, et al.. (1998). Effects of Cyclooxygenase-2 Selective and Nitric Oxide-Releasing Nonsteroidal Antiinflammatory Drugs on Mucosal Ulcerogenic and Healing Responses of the Stomach. Digestive Diseases and Sciences. 43(9). 2003–2011. 76 indexed citations
13.
Takeuchi, Koji, et al.. (1998). Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.. PubMed. 49(4). 501–13. 31 indexed citations
14.
Ukawa, Hideki, et al.. (1998). Effects of cyclooxygenase-2 (COX-2) selective and nitric oxide (NO)-releasing NSAIDs on mucosal ulcerogenic and healing responses of the stomach. The Japanese Journal of Pharmacology. 76. 121–121. 2 indexed citations
15.
Ukawa, Hideki, et al.. (1997). Effects of selective cyclooxygenase-2 inhibitors on alkaline secretory and mucosal ulcerogenic responses in rat duodenum. Life Sciences. 61(16). 1603–1611. 21 indexed citations
16.
Takeuchi, Koji, et al.. (1997). Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology. 113(5). 1553–1559. 112 indexed citations
17.
Konaka, Akira, et al.. (1997). Role of nitric oxide in pathogenesis of gastric mucosal damage induced by compound in rats. Journal of Physiology-Paris. 91(3-5). 131–138. 25 indexed citations
18.
Ukawa, Hideki, et al.. (1997). Cyclo‐oxygenase isozymes in mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. British Journal of Pharmacology. 122(3). 447–454. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026